Answers are grounded in this paper and cite their sources.
Clinical trial regulations should remove unnecessary obstacles for the conduct of pragmatic trials assessing the comparative effectiveness of medicines posing no or minimal risk to participants, say Rafael Dal-Ré and colleagues
No takes yet. Share an insight, caveat, or question.
Dal‐Ré et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: